Sunitinib malate (LC Laboratories) and its vehicle, formulated as previously described (5), were delivered by oral gavage (per os). Regorafenib monohydrate (Bayer HealthCare) was dissolved in a vehicle formulation containing 1,2-propanediol (34% w/v), PEG-400 (34% w/v), Kolliphor P188 (12% w/v), and Super-Q water (20% v/v) for per os administration. CVX-060/CVX-2000/ CVX-241 (Pfizer), DC101 (ImClone/Eli Lilly), and an antibody to mouse PD-L1 (clone 10F.9G2, BioXCell #BE0101) were diluted in PBS for intraperitoneal administration.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.
Tips for asking effective questions
+ Description
Write a detailed description. Include all information that will help others answer your question including experimental processes, conditions, and relevant images.